Search research articles
Contact Us
Filters
Showing results (111-120 of 175) with videos related to
Page
of 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2014
Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis
Anika L Dzierlenga, John D Clarke, Tiffanie L Hargraves, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 16, 2011
Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models
Grace Zhixia Yan, Kim L R Brouwer, Gary M Pollack, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2023
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants
Sumit Bansal, C Austin Zamarripa, Tory R Spindle, et al.
Therapeutic Drug Monitoring
|
January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach
Joseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2002
Identification of a novel route of extraction of sirolimus in human small intestine: roles of metabolism and secretion
Mary F Paine, Louis Y Leung, H K Lim, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 28, 2019
Indinavir Increases Midazolam <i>N</i>-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach
Dan-Dan Tian, Cathrine Leonowens, Emily J Cox, et al.
Clinical Pharmacology and Therapeutics
|
May 22, 2025
From Discovery to Translation: Endogenous Substrates of OAT1 and OAT3 as Clinical Biomarkers for Renal Secretory Function
Aarzoo Thakur, Dilip K Singh, Katherine D Hart, et al.
Journal of Clinical Pharmacology
|
July 24, 2013
A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect"
Christina S Won, Tian Lan, Karen M Vandermolen, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 175) with videos related to
Sort By:
Page
of 18
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2014
Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis
Anika L Dzierlenga, John D Clarke, Tiffanie L Hargraves, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 16, 2011
Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models
Grace Zhixia Yan, Kim L R Brouwer, Gary M Pollack, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2023
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants
Sumit Bansal, C Austin Zamarripa, Tory R Spindle, et al.
Therapeutic Drug Monitoring
|
January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach
Joseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2002
Identification of a novel route of extraction of sirolimus in human small intestine: roles of metabolism and secretion
Mary F Paine, Louis Y Leung, H K Lim, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 28, 2019
Indinavir Increases Midazolam <i>N</i>-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach
Dan-Dan Tian, Cathrine Leonowens, Emily J Cox, et al.
Clinical Pharmacology and Therapeutics
|
May 22, 2025
From Discovery to Translation: Endogenous Substrates of OAT1 and OAT3 as Clinical Biomarkers for Renal Secretory Function
Aarzoo Thakur, Dilip K Singh, Katherine D Hart, et al.
Journal of Clinical Pharmacology
|
July 24, 2013
A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect"
Christina S Won, Tian Lan, Karen M Vandermolen, et al.
Page
of 18